[go: up one dir, main page]

Weston et al., 2005 - Google Patents

Reconstitution of hepatitis C virus–specific T‐cell–mediated immunity after liver transplantation

Weston et al., 2005

View PDF @Full View
Document ID
11526336205343496560
Author
Weston S
Leistikow R
Reddy K
Torres M
Wertheimer A
Lewinsohn D
Chou S
Davey M
Corless C
O'Farrelly C
Nelson D
Rosen H
Publication year
Publication venue
Hepatology

External Links

Snippet

Hepatitis C virus (HCV)‐related liver failure is the leading indication for liver transplantation worldwide. After transplantation, virological recurrence is the rule, but the spectrum of histological injury is wide, ranging from the development of allograft cirrhosis within a few …
Continue reading at aasldpubs.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Similar Documents

Publication Publication Date Title
Weston et al. Reconstitution of hepatitis C virus–specific T‐cell–mediated immunity after liver transplantation
Wertheimer et al. Novel Cd4+ and Cd8+ T–Cell Determinants Within the Ns3 Protein in Subjects With Spontaneously Resolved Hcv Infection
Eggenhuizen et al. BCG vaccine derived peptides induce SARS-CoV-2 T cell cross-reactivity
Rahman et al. Effects of antiviral therapy on the cellular immune response in acute hepatitis C
Kanto et al. Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity
Shoukry et al. Cell-mediated immunity and the outcome of hepatitis C virus infection
Golden‐Mason et al. Loss of IL‐7 receptor alpha‐chain (CD127) expression in acute HCV infection associated with viral persistence
Shresta et al. Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice
Valiante et al. Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C
Burke et al. Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence
Ma et al. The role of NK cells in fighting the virus infection and sepsis
Kelly et al. Chronic hepatitis C viral infection subverts vaccine‐induced T‐cell immunity in humans
Rosen Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury
JP5568309B2 (en) CTL inducer composition
Li et al. Defining target antigens for CD25+ FOXP3+ IFN‐γ− regulatory T cells in chronic hepatitis C virus infection
Woollard et al. Characterization of Hcv–Specific Patr Class Ii Restricted Cd4+ T Cell Responses in An Acutely Infected Chimpanzee
Hempel et al. Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon‐α‐treated patients with chronic hepatitis C
US20080044433A1 (en) Epitopes of hepatitis C virus
Bes et al. Reversal of nonstructural protein 3‐specific CD4+ T cell dysfunction in patients with persistent hepatitis C virus infection
Godkin et al. Expansion of hepatitis C–specific CD4+ CD25+ regulatory T cells after viral clearance: A mechanism to limit collateral damage?
Krishnadas et al. In vitro activation and differentiation of naive CD4+ and CD8+ T cells into HCV core-and NS3-specific armed effector cells: a new role for CD4+ T cells
Zhu et al. Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL
WO2021119293A2 (en) T-cell epitopes of human parainfluenza virus 3 for adoptive t-cell immunotherapy
Hartnell et al. Characterisation of HCV specific CD4+ T-cells in viral vectored vaccination, following DAA cure and after spontaneous viral clearance
Han et al. Identification of the association of CD28+ CD244+ Tc17/IFN‐γ cells with chronic hepatitis C virus infection